RIPK1 and autoimmune hepatitis: Of concern, was the observation that in concanavalin A (ConA)-induced autoimmune hepatitis, RIPK3 deletion was protective, whereas RIPK1 inhibition exacerbated disease, accelerated animal death, and was associated with increased hepatocyte cell death [40].